Literature DB >> 1301849

[Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus].

X Z Zhao1.   

Abstract

Natural killer (NK) activity of peripheral blood mononuclear cells (PBMC) from 28 patients with systemic lupus erythematosus (SLE) was measured using enzyme-release assay. The SLE patients had significantly decreased NK activity in comparing with normal controls. The levels of NK activity correlated with disease activity. Pre-incubation of PBMC separately with Astragalus membranaceus and Tripterygium hypoglaucum or with their mixture considerably stimulated NK cytotoxicity both in SLE patients and healthy donors. The extent of enhancement was dose-dependent and relevant to pre-incubation periods. The release of a soluble natural killer cytotoxic factor (NKCF) by peripheral blood mononuclear cells was tested by cytotoxicity assay induced in K562 cells. Natural killer cytotoxic factor release was significantly lower in SLE patients than in controls. The levels of natural killer cytotoxic factor were correlated well with NK activities, but correlated negatively with clinical activity. Pre-incubated supernatants from peripheral blood mononuclear cells with above-mentioned agents caused much higher percentage of lysis on K562 targets than that of without pre-incubation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1301849

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  7 in total

1.  A Pragmatic Approach to Immunity & Respiratory Viral Infections.

Authors:  Todd A Born
Journal:  Integr Med (Encinitas)       Date:  2020-10

Review 2.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

3.  Astragalus saponins affect proliferation, invasion and apoptosis of gastric cancer BGC-823 cells.

Authors:  Tao Wang; Xiaoyan Xuan; Min Li; Ping Gao; Yuling Zheng; Wenqiao Zang; Guoqiang Zhao
Journal:  Diagn Pathol       Date:  2013-10-24       Impact factor: 2.644

4.  Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment.

Authors:  Itzchak H Rachmut; Noah Samuels; Steven J Melnick; Cheppail Ramachandran; Yedida Sharabi; Anya Pavlovsky; Yair Maimon; Jacob Shoham
Journal:  Onco Targets Ther       Date:  2013-04-24       Impact factor: 4.147

5.  Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial.

Authors:  Qiuxia Li; Li Li; Liqi Bi; Changhong Xiao; Zhiming Lin; Shuangyan Cao; Zetao Liao; Jieruo Gu
Journal:  Trials       Date:  2016-07-22       Impact factor: 2.279

6.  Clinical and Preclinical Systematic Review of Astragalus Membranaceus for Viral Myocarditis.

Authors:  Qun Zheng; Zhuang Zhuang; Zi-Hao Wang; Li-Hui Deng; Wang-Jun Jin; Zi-Jun Huang; Guo-Qing Zheng; Yan Wang
Journal:  Oxid Med Cell Longev       Date:  2020-11-02       Impact factor: 6.543

7.  Tripterygium and its plant extraction for systemic lupus erythematosus: A protocol for systematic review and meta analysis.

Authors:  Fangying Chen; Junting Liu; Zhimin Zhao; Ziping Li; Kuanyu Wu
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.